Fidelity Investments
BLFS icon

Fidelity Investments’s BioLife Solutions BLFS Stock Holding History

Fidelity Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Sell
993,106
-477,146
-32% -$11.2M ﹤0.01% 1747
2026
Q1 		$28.1M Sell
1,470,252
-77,942
-5% -$1.72M ﹤0.01% 1655
2025
Q4 		$37.4M Buy
1,548,194
+532,423
+52% +$13.9M ﹤0.01% 1546
2025
Q3 		$25.9M Buy
1,015,771
+1,012,690
+32,869% +$24M ﹤0.01% 1662
2025
Q2 		$66.4K Sell
3,081
-11,047
-78% -$249K ﹤0.01% 3769
2025
Q1 		$323K Buy
14,128
+671
+5% +$17.7K ﹤0.01% 3062
2024
Q4 		$349K Buy
13,457
+140
+1% +$3.48K ﹤0.01% 3051
2024
Q3 		$333K Buy
13,317
+10,983
+471% +$259K ﹤0.01% 3014
2024
Q2 		$50K Buy
2,334
+355
+18% +$6.89K ﹤0.01% 3618
2024
Q1 		$36.7K Sell
1,979
-287,783
-99% -$5.03M ﹤0.01% 3741
2023
Q4 		$4.71M Sell
289,762
-1,343
-0.5% -$17.1K ﹤0.01% 2087
2023
Q3 		$4.02M Buy
291,105
+506
+0.2% +$7.97K ﹤0.01% 2107
2023
Q2 		$6.42M Sell
290,599
-4,993
-2% -$105K ﹤0.01% 1989
2023
Q1 		$6.43M Buy
295,592
+1,875
+0.6% +$42.2K ﹤0.01% 2019
2022
Q4 		$5.35M Sell
293,717
-26,510
-8% -$547K ﹤0.01% 2097
2022
Q3 		$7.29M Sell
320,227
-39,104
-11% -$837K ﹤0.01% 2034
2022
Q2 		$4.96M Buy
359,331
+63,835
+22% +$937K ﹤0.01% 2238
2022
Q1 		$6.72M Sell
295,496
-94,604
-24% -$2.49M ﹤0.01% 2274
2021
Q4 		$14.5M Buy
390,100
+162,500
+71% +$6.97M ﹤0.01% 1967
2021
Q3 		$9.63M Buy
227,600
+14,500
+7% +$698K ﹤0.01% 2142
2021
Q2 		$9.48M Hold
213,100
– – ﹤0.01% 2129
2021
Q1 		$7.67M Sell
213,100
-2,500
-1% -$98.9K ﹤0.01% 2134
2020
Q4 		$8.6M Buy
215,600
+62,450
+41% +$2.13M ﹤0.01% 2017
2020
Q3 		$4.43M Buy
+153,150
New +$3.31M ﹤0.01% 2106
2019
Q4 		– Sell
-150,000
Closed -$2.49M – 3788
2019
Q3 		$2.49M Hold
150,000
– – ﹤0.01% 2220
2019
Q2 		$2.54M Hold
150,000
– – ﹤0.01% 2267
2019
Q1 		$2.68M Buy
+150,000
New +$2.39M ﹤0.01% 2232

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments's BLFS Position: Q2 2026 in Review

Fidelity Investments reduced its BioLife Solutions (BLFS) stake by 32% in Q2 2026, selling an estimated $11.2M and leaving 993,106 shares worth $28M. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Fidelity Investments first reported a position in BLFS in Q1 2019 and has held it in 27 quarters since. The position peaked at $37.4M in Q4 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Fidelity Investments held 993,106 shares of BioLife Solutions worth $28M as of Q2 2026.
  • Fidelity Investments sold 477,146 BioLife Solutions shares in Q2 2026, an estimated $11.2M.
  • BioLife Solutions made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1747 holding.
  • Fidelity Investments first reported a position in BioLife Solutions in Q1 2019 and has held it in 27 quarters since.
  • Fidelity Investments's BioLife Solutions position peaked at $37.4M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.